Efficacy of a novel PEGylated humanized andti-TNF fragment (CD870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escating trial

Choy, C, Hazleman, B, Smith, M, Moss, K, Lisi, L, Scott, DGI, Patel, J, Sopwith, M and Isenberg, D (2002) Efficacy of a novel PEGylated humanized andti-TNF fragment (CD870) in patients with rheumatoid arthritis: a phase II double-blinded, randomized, dose-escating trial. Rheumatology, 41 (10). pp. 1133-1137. ISSN 1462-0324

Full text not available from this repository. (Request a copy)

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User:	EPrints Services
Date Deposited:	25 Nov 2010 11:09
Last Modified:	23 Oct 2022 19:32
URI:	https://ueaeprints.uea.ac.uk/id/eprint/12346
DOI:	10.1093/rheumatology/41.10.1133

Actions (login required)

View Item